TPTX insider transactions
Turning Point Therapeutics Inc. (TPTX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for TPTX
- SEC Form 4 filed by Nicholson Garry A (tax withholding)4 - Turning Point Therapeutics, Inc. (0001595893) (Issuer)
- SEC Form 4 filed by Machado Patrick (withholding obligation)4 - Turning Point Therapeutics, Inc. (0001595893) (Issuer)
- SEC Form 4: George Simeon returned $171,278,160 worth of shares to the company (2,253,660 units at $76.00) to cover taxes4 - Turning Point Therapeutics, Inc. (0001595893) (Issuer)
- SEC Form 4 filed by Gallagher Carol Giltner to satisfy tax liability4 - Turning Point Therapeutics, Inc. (0001595893) (Issuer)
- SEC Form 4 filed by Bodem Barbara W.4 - Turning Point Therapeutics, Inc. (0001595893) (Issuer)
- SEC Form 4: Alles Mark J returned $152,000 worth of shares to the company (2,000 units at $76.00), closing all direct ownership in the company to satisfy withholding tax4 - Turning Point Therapeutics, Inc. (0001595893) (Issuer)
- SEC Form 4: Tombesi Paolo returned $2,263,128 worth of shares to the company (29,778 units at $76.00), closing all direct ownership in the company to cover withholding tax4 - Turning Point Therapeutics, Inc. (0001595893) (Issuer)
- SEC Form 4: Sun Brian returned $3,420,000 worth of shares to the company (45,000 units at $76.00), closing all direct ownership in the company (tax liability)4 - Turning Point Therapeutics, Inc. (0001595893) (Issuer)
- SEC Form 4: Sabus Steve M returned $2,786,692 worth of shares to the company (36,667 units at $76.00), closing all direct ownership in the company (withholding obligation)4 - Turning Point Therapeutics, Inc. (0001595893) (Issuer)
- SEC Form 4: Hirmand Mohammad returned $3,137,584 worth of shares to the company (41,284 units at $76.00), closing all direct ownership in the company to cover withholding tax4 - Turning Point Therapeutics, Inc. (0001595893) (Issuer)
- SEC Form 4: Countouriotis Athena returned $8,432,884 worth of shares to the company (110,959 units at $76.00), closing all direct ownership in the company (withholding tax)4 - Turning Point Therapeutics, Inc. (0001595893) (Issuer)
- SEC Form 4: Tombesi Paolo sold $88,654 worth of shares (1,183 units at $74.94), decreasing direct ownership by 4% to 28,700 units (withholding tax)4 - Turning Point Therapeutics, Inc. (0001595893) (Issuer)
- SEC Form 4: Sabus Steve M was granted 36,667 shares4 - Turning Point Therapeutics, Inc. (0001595893) (Issuer)
- SEC Form 3 filed by new insider Sabus Steve M3 - Turning Point Therapeutics, Inc. (0001595893) (Issuer)
- SEC Form 4: Sun Brian was granted 45,000 shares4 - Turning Point Therapeutics, Inc. (0001595893) (Issuer)
- SEC Form 3 filed by new insider Sun Brian3 - Turning Point Therapeutics, Inc. (0001595893) (Issuer)
- SEC Form 4: Tombesi Paolo was granted 16,283 shares, increasing direct ownership by 120% to 29,883 units4 - Turning Point Therapeutics, Inc. (0001595893) (Issuer)
- SEC Form 4: Reich Siegfried sold $14,411 worth of shares (397 units at $36.30) and was granted 13,567 shares, increasing direct ownership by 343% to 17,015 units to satisfy withholding obligation4 - Turning Point Therapeutics, Inc. (0001595893) (Issuer)
- SEC Form 4: Partridge Andrew John sold $8,022 worth of shares (221 units at $36.30) and was granted 16,283 shares, increasing direct ownership by 72% to 38,361 units (withholding obligation)4 - Turning Point Therapeutics, Inc. (0001595893) (Issuer)
- SEC Form 4: North Annette sold $24,285 worth of shares (669 units at $36.30) and was granted 16,283 shares, increasing direct ownership by 126% to 27,979 units to satisfy tax liability4 - Turning Point Therapeutics, Inc. (0001595893) (Issuer)
- SEC Form 4: Hirmand Mohammad sold $24,285 worth of shares (669 units at $36.30) and was granted 33,983 shares, increasing direct ownership by 444% to 40,821 units (for withholding tax)4 - Turning Point Therapeutics, Inc. (0001595893) (Issuer)
- SEC Form 4: Countouriotis Athena sold $107,847 worth of shares (2,971 units at $36.30) and was granted 62,400 shares, increasing direct ownership by 117% to 110,330 units (withholding obligation)4 - Turning Point Therapeutics, Inc. (0001595893) (Issuer)
- SEC Form 4: North Annette exercised 10,000 units of Common Stock at a strike of $17.00 and sold $800,000 worth of Common Stock (10,000 units at $80.00)4 - Turning Point Therapeutics, Inc. (0001595893) (Issuer)
- SEC Form 3 filed by TOMBESI PAOLO3 - Turning Point Therapeutics, Inc. (0001595893) (Issuer)
- SEC Form 4 filed by Turning Point Therapeutics, Inc.4 - Turning Point Therapeutics, Inc. (0001595893) (Issuer)
- SEC Form 4 filed by Turning Point Therapeutics, Inc.4 - Turning Point Therapeutics, Inc. (0001595893) (Issuer)
- SEC Form 4: Alles Mark J bought $162,680 worth of Common Stock (2,000 units at $81.34)4 - Turning Point Therapeutics, Inc. (0001595893) (Issuer)
- SEC Form 4: North Annette exercised 15,000 units of Common Stock at a strike of $17.00 and sold $1,155,433 worth of Common Stock (15,000 units at $77.03)4 - Turning Point Therapeutics, Inc. (0001595893) (Issuer)
- SEC Form 4 filed by Turning Point Therapeutics, Inc.4 - Turning Point Therapeutics, Inc. (0001595893) (Issuer)
- SEC Form 4 filed by Machado Patrick4 - Turning Point Therapeutics, Inc. (0001595893) (Issuer)
- SEC Form 4 filed by Turning Point Therapeutics, Inc.4 - Turning Point Therapeutics, Inc. (0001595893) (Issuer)
- SEC Form 4 filed by Nicholson Garry A4 - Turning Point Therapeutics, Inc. (0001595893) (Issuer)
- SEC Form 4 filed by Turning Point Therapeutics, Inc.4 - Turning Point Therapeutics, Inc. (0001595893) (Issuer)
- SEC Form 4 filed by Turning Point Therapeutics, Inc.4 - Turning Point Therapeutics, Inc. (0001595893) (Issuer)
- SEC Form 3 filed by Alles Mark J3 - Turning Point Therapeutics, Inc. (0001595893) (Issuer)
- SEC Form 3 filed by Van Hoose Kyri K.3 - Turning Point Therapeutics, Inc. (0001595893) (Issuer)
- SEC Form 4: North Annette exercised 5,882 units of Common Stock at a strike of $17.00, increasing direct ownership by 91% to 12,365 units4 - Turning Point Therapeutics, Inc. (0001595893) (Issuer)
- SEC Form 4 filed by W. Barbara Bodem4 - Turning Point Therapeutics, Inc. (0001595893) (Issuer)
- SEC Form 3 filed by W. Barbara Bodem3 - Turning Point Therapeutics, Inc. (0001595893) (Issuer)
- SEC Form 4: Lee Brian Baker exercised 28,435 units of Common Stock at a strike of $4.67, sold $2,862,082 worth of Common Stock (28,435 units at $100.65) and was granted 1,625 units of Common Stock, increasing direct ownership by 65% to 4,116 units4 - Turning Point Therapeutics, Inc. (0001595893) (Issuer)
- SEC Form 4: Annette North exercised 20,000 units of Common Stock at a strike of $17.00 and sold $2,195,939 worth of Common Stock (20,000 units at $109.80)4 - Turning Point Therapeutics, Inc. (0001595893) (Issuer)
- SEC Form 4: Siegfried Reich sold $3,734,075 worth of Common Stock (35,550 units at $105.04) and exercised 35,550 units of Common Stock at a strike of $51.284 - Turning Point Therapeutics, Inc. (0001595893) (Issuer)
- SEC Form 4: Athena Countouriotis exercised 60,000 units of Common Stock at a strike of $3.20 and sold $8,249,038 worth of Common Stock (60,000 units at $137.48)4 - Turning Point Therapeutics, Inc. (0001595893) (Issuer)
- SEC Form 4: Mohammad Hirmand was granted 6,483 units of Common Stock, increasing ownership by 2,283% to 6,767 units4 - Turning Point Therapeutics, Inc. (0001595893) (Issuer)
- SEC Form 4: Annette North was granted 6,483 units of Common Stock4 - Turning Point Therapeutics, Inc. (0001595893) (Issuer)
- SEC Form 4: John Andrew Partridge was granted 2,136 units of Common Stock, increasing ownership by 10% to 23,636 units4 - Turning Point Therapeutics, Inc. (0001595893) (Issuer)
- SEC Form 4: Yi Larson was granted 4,617 units of Common Stock, increasing ownership by 171% to 7,321 units4 - Turning Point Therapeutics, Inc. (0001595893) (Issuer)
- SEC Form 4: Siegfried Reich was granted 3,845 units of Common Stock4 - Turning Point Therapeutics, Inc. (0001595893) (Issuer)
- SEC Form 4: Lee Brian Baker was granted 1,483 units of Common Stock, increasing ownership by 147% to 2,491 units4 - Turning Point Therapeutics, Inc. (0001595893) (Issuer)
- SEC Form 4: Athena Countouriotis was granted 22,617 units of Common Stock, increasing ownership by 82% to 50,195 units4 - Turning Point Therapeutics, Inc. (0001595893) (Issuer)
- SEC Form 4: Annette North exercised 25,000 units of Common Stock at a strike of $17.00 and sold $3,147,363 worth of Common Stock (25,000 units at $125.89)4 - Turning Point Therapeutics, Inc. (0001595893) (Issuer)
- SEC Form 4: Yi Larson exercised 30,000 units of Common Stock at a strike of $54.03 and sold $3,801,918 worth of Common Stock (30,000 units at $126.73)4 - Turning Point Therapeutics, Inc. (0001595893) (Issuer)